Clinical Trials Directory

Trials / Completed

CompletedNCT06230679

Effectiveness of NESA in the Treatment of Cancer Survivors

Effectiveness of NESA in the Treatment of Sleep Problems, Fatigue, and Neuromuscular Pain in Cancer Survivors.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
40 (actual)
Sponsor
Aníbal Báez Suárez · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Cancer is a disease, or a set of diseases, that increased in our society. However, improvements in their detection and treatment increase the number of patients who survive. Every year 2.6 million people are diagnosed in the European Union and 1.4 million become cancer survivors. However, these people suffer the late adverse effects of treatment that can seriously affect their quality of life. the most common late effects are pain, fatigue, and sleeping difficulties. These are estimated between 58-90%. The autonomic nervous system (ANS) appears to play an important role in the manifestation and perpetuation of these symptoms.

Detailed description

This study aims to evaluate NESA (or NESA non-invasive neuromodulation) to treat the most common long-term side effects in cancer survivors, due to the most used treatments. It will be compared between two groups of cancer survivors. The intervention group, with electrical stimulation, and the sham group, without electrical stimulation emission. The subjects will be assigned randomly. Neither the patient, the therapist, nor the analysts/researchers will know the assignment. Finally, this project aims to add a passive tool to the therapeutic arsenal of health professionals in the oncology field for the treatment of late side effects.

Conditions

Interventions

TypeNameDescription
DEVICENon-invasive NeuromodulationPatients receive non-invasive neurostimulation through the Nesa device
DEVICEPlacebo Non-invasive NeuromodulationThe same protocol described for the experimental group will be applied, but electrical stimulation device which will be previously manipulated and tested with an oscilloscope so that they do not emit electrical currents.

Timeline

Start date
2024-01-19
Primary completion
2025-09-19
Completion
2025-12-19
First posted
2024-01-30
Last updated
2026-01-16

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT06230679. Inclusion in this directory is not an endorsement.

Effectiveness of NESA in the Treatment of Cancer Survivors (NCT06230679) · Clinical Trials Directory